Average Co-Inventor Count = 5.15
ph-index = 7
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Praecis Pharmaceuticals, Inc. (9 from 43 patents)
2. Provid Pharmaceuticals Inc. (4 from 6 patents)
3. University of California (1 from 15,475 patents)
4. The United States of America, As Represented by the Secretary, Department of Health and Human Services (1 from 3,539 patents)
5. Sequenom, Inc. (1 from 186 patents)
14 patents:
1. 8765802 - Kinase inhibitors, compositions thereof, and methods of use therewith
2. 8598312 - Inhibitors of antigen presentation by MHC class II molecules
3. 8222215 - Methods for the use of inhibitors of antigen presentation by MHC class II molecules
4. 7439231 - Inhibitors of antigen presentation by MHC class II molecules and methods of use thereof
5. 7432342 - Kinase anchor protein muteins, peptides thereof and related documents
6. 7405194 - Therapeutic agents and methods of use thereof for the treatment of melanoma
7. 7348307 - Methionine aminopeptidase-2 inhibitors and methods of use thereof
8. 7268111 - Therapeutic agents and methods of use thereof for the modulation of angiogenesis
9. 7157420 - Therapeutic agents and methods of use thereof for the modulation of angiogenesis
10. 7105482 - Methionine aminopeptidase-2 inhibitors and methods of use thereof
11. 7084108 - Therapeutic agents and methods of use thereof for the modulation of angiogenesis
12. 7037890 - Therapeutic agents and methods of use thereof for the modulation of angiogenesis
13. 6919307 - Therapeutic agents and methods of use thereof for the modulation of angiogenesis
14. 6548477 - Therapeutic agents and methods of use thereof for the modulation of angiogenesis